Last updated: April 14, 2021
Sponsor: Hamad Medical Corporation
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Stones
Treatment
N/AClinical Study ID
NCT04851171
MRC-01-19-036
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years
- Single proximal ureteric stone indicated for active treatment with ureteroscopy (stented or non-stented)
Exclusion
Exclusion Criteria:
- Solitary Kidney
- Bilateral ureteric stones
- Ipsilateral multiple simultaneous ureteric stones
- Ipsilateral kidney stone
- Active UTI
- Coagulopathy diseases
- Ipsilateral ureteral anomalies, ureteral disorder (tumor or stricture) or previousureteral open surgery.
- Pregnant patients.
- Unable to give informed consent.
- Patient is not agreeing to go through the randomization.
Study Design
Total Participants: 140
Study Start date:
November 26, 2020
Estimated Completion Date:
January 31, 2023
Study Description
Connect with a study center
Al Wakra Hospital
Al-Wakrah, Doha 0000
QatarActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.